Post-laparoscopic oral contraceptive combined with Chinese herbal mixture in treatment of infertility and pain associated with minimal or mild endometriosis: a randomized controlled trial by unknown
Zhu et al. BMC Complementary and Alternative Medicine 2014, 14:222
http://www.biomedcentral.com/1472-6882/14/222RESEARCH ARTICLE Open AccessPost-laparoscopic oral contraceptive combined
with Chinese herbal mixture in treatment of
infertility and pain associated with minimal or
mild endometriosis: a randomized controlled trial
Shaomi Zhu†, Dong Liu†, Wei Huang*, Qiushi Wang, Qiuyi Wang, Lu Zhou and Guimei FengAbstract
Background: Endometriosis affects fertility negatively. The study aims to evaluate whether laparoscopic surgery
combined with oral contraceptive or herbs were more effective than laparoscopic alone in improving fecundity and
pelvic pain in women with minimal/mild endometriosis.
Methods: A randomized controlled trial (RCT) was conducted in 156 infertile women with minimal/mild
endometriosis. After laparoscopic surgery, patients were randomized to three groups: in Group A (n = 52) oral
contraceptive (OC) was administered one pill a day, continuous for 63 days without intervals, in Group B (n = 52)
OC was administered as above and then Dan’e mixture was added 30 g/day for the latter 30 days, and in control
Group C (n = 52) patients tried to get pregnant after surgery without complementary treatment. The follow-up
periods were 12 months in Group C and 14 months in complementary medical treatment Group A and B. The
pregnant women were further followed up, and labor and pregnancy outcomes were assessed. Primary outcome
was pregnancy rate (PR) and live birth rate (LBR). Secondary outcomes included changes of pelvic pain visual analog
scale scores and side effects. Analyses were done as intention-to-treat.
Results: The PR was 46.80% (73/156), and the LBR was 69.86% (51/73). Of the 73 pregnancies, 60 occurred within
12 months of follow-up and 7 of the remaining 13 patients underwent assisted reproductive technology for >1 year.
No significant difference was observed in PR and LBR among the three groups. Patients given medical treatment
(OCs or OCs plus herbal medicine) had significantly decreased pain scores compared with the laparoscopy alone
group.
Conclusions: Combination of laparoscopy with OCs or OCs and herbal medicine does not have more advantages
than laparoscopy alone in improving fertility of women with minimal/mild endometriosis.
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Endometriosis is a condition in which endometrial glands
and stromal implants grow outside the uterus, causing
chronic pelvic pain and infertility. It is reported that
30–50% of women with endometriosis are infertile [1]. Of
the patients with endometriosis, 32% have moderate to
severe disease, while 58% have minimal or mild endome-
triosis [2]. The pathogenesis of mild/minimal endometrio-
sis associated with infertility is rather unclear. Therefore,
current therapy for these women involves the use of surgi-
cal methods including laparoscopy, expectant treatment,
induced ovulation, and assisted reproductive technology
(ART) [3,4] and medication that induces a pseudomeno-
pause or pseudopregnancy state.
A Canadian RCT involving 341 women with minimal
or mild disease followed up for 36 weeks after laparos-
copy reported that surgery was more effective than no
treatment and treatment with pharmaceutical agents
alone [5]. However, with laparoscopy, all parts of the le-
sion cannot be removed completely. Moreover, postoper-
ative treatment with drugs is still a controversial issue
[6-8]. Therefore, there is a need to determine the useful-
ness of postoperative medical treatment in these cases,
which is what our study set out to do.
As one of the first-line treatments for pelvic pain asso-
ciated with endometriosis, OCs are highly safe, fewer side
effects, and cost-effective. However, only a few RCTs have
reported the use of OCs in the treatment of minimal/mild
endometriosis after surgery [9,10]. Therefore, the ability of
laparoscopy combined with OCs to improve fertility that
occur secondary to minimal/mild endometriosis remains
debatable.
Chinese traditional medicines have also long been in use
for the treatment of endometriosis. Dan’e mixture is a
combination of qi-regulating and blood-vitalizing herbs,
mainly composed of danshen (salvia), ezhu (zedoaria),
chishao (red peony), danggui (tang-kuei), chaihu (buple-
urum) and yanhusuo (corydalis). Dan’e mixture displayed
similar effects to Danazol in the treatment of infertility
and pelvic pain associated with endometriosis. However,
no clinical data on Dan’e mixture for treatment in infertile
women with minimal/mild endometriosis is found now. A
rigorous randomized controlled trial is necessary. In our
study, we speculated on whether a combination of OCs
and herbal medicines can improve fertility in these
women. There is currently no published study comparing
OCs with a combination of OCs and herbs. In addition,
there is no adequate powered randomized trial that has
studied the effectiveness of laparoscopy combined with
medical treatment compared to surgery alone in women
with infertility and pain secondary to minimal/mild
endometriosis.
In this prospective, randomized controlled study, we
compared laparoscopy alone with laparoscopy followedby treatment with OCs or a combination of OCs and the
Dan’e mixture in the treatment of minimal/mild endo-
metriosis, primarily with regard to improvement of fe-
cundity and alleviation of pelvic pain.
Methods
Study population
The study was conducted at the Department of Obstetrics
and Gynecology, West China Second Hospital of Sichuan
University, from February 2011 to May 2013. It was con-
ducted in accordance with the ethical principles of the
Helsinki Declaration, and the study protocol was approved
by the ethics committee of the hospital. The trial is
reported and was analyzed in accordance with the
CONSORT criteria. All the included patients signed an
informed consent form before participation. The study
population was infertile women with minimal or mild
endometriosis confirmed by laparoscopy, according to the
revised American Fertility Society (r-AFS) classification
(r-AFS score < 16) [11]. The study included women aged
20 to 40 years who wished to conceive and had failed to
get pregnant after at least 12 months of unprotected inter-
course. Women were excluded if they had previously
undergone medical or surgical treatments for endometri-
osis; if their infertility resulted from problems with the
ovary, fallopian tube, or uterus, or other causes such as
adenomyosis, ovarian endometrioma or deep endome-
triosis; or if the male partner had abnormal sperm cells
or was suspected to have any gynecologic malignancies.
Women with contraindications for OCs such as severe
diabetes and hypertension, hepatic or renal dysfunction,
and idiopathic vagina bleeding were also not included.
Sample size
Sample size calculations were based on the assumption
that there would be a 15% difference between pregnant
rate [5]. When an α value of 0.05 with power 80% and a
20% dropout rate were considered, the sample size of
each group was determined to be 52.
Study design
All patients underwent laparoscopy under general an-
esthesia. All apparent endometriosis lesions, including
superficial endometriomas and implant lesions, were ex-
cised or cauterized by monopolar or bipolar electrocaute-
rization. The pelvic and fallopian adhesions were detected
and lysed to restore normal anatomy. The patency of the
fallopian tube was examined using methylene blue during
laparoscopy, and finally about 2000 ml of 0.9% normal
saline was used to wash the pelvis thoroughly.
After the operation, the patients were randomly allo-
cated to three groups: Group A: an OC (Marvelon: 30 μg
ethinyl estradiol and 150 μg desogestrel/tablet) was ad-
ministered one tablet continuously for 63 days, Group B:
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63 days and the Dan’e mixture (manufactured by DIHON
Medicine, Yunnan Province, China) was administered at
30 g/day for the latter 30 days, Group C: no medical treat-
ment was given (Figure 1). The patients in Group C were
prepared to conceive after their one-month visit, and the
patients in Group A and Group B were prepared to con-
ceive after they experienced withdrawal bleeding at the
end of medical treatment. Each participant was asked to
self-estimate pelvic pain (dysmenorrhea, noncyclic pelvic
pain, and deep dyspareunia) using a visual analogue scale
(VAS), with a score of 0 indicating no pain and 10 indica-
ting the worst pain imaginable. The random allocation
was conducted using a computer-generated list of random
numbers. The codes A, B, and C were placed separately in
three sealed envelopes; they were sequentially numbered
and then chronologically opened in the ward only after an
eligible patient was identified. The study would be can-
celled when the participant appeared apparently side effect
of any medicine or desired to stop the treatment.
Follow-up
All participants completed their one-month visit after
surgery, where their menstrual status was noted and their
recovery was ensured. Then, they were regularly followed
up via the phone or outpatient visits every three months
for 12 months in Group C and 14 months in complemen-
tary medical treatment Group A and B. The pregnant
women were further followed up, and labor and pregnancyRando
n=
















Figure 1 Flow chart of study.outcomes were assessed. Those who failed to conceive at
12 months of follow-up were advised to undergo ART in
the form of intrauterine insemination (IUI) or in vitro
fertilization (IVF). The VAS pain score and side effects of
the medical treatment such as gastrointestinal reactions,
irregular vaginal bleeding, and weight gain were assessed
at every visit.
The primary outcomes were PR and live birth (delivery
of a take-home baby) rate (LBR). Miscarriages (fetal loss
at <20 weeks of gestation, preterm delivery (births bet-
ween 20 to 37 weeks), stillbirth (fetal loss after ≥28 weeks
of gestation or birth weight ≥ 1000 g) and obstetric com-
plications were also defined. The secondary outcomes
were VAS pain scores, and the side effects of the medicine
were also investigated.
Statistical analysis
Statistical analyses were performed with SPSS 17.0 for
Windows. Continuous data were tested for normality
using histograms and normal Q-Q plots. For variables with
abnormal distribution, the non-parametric Kruskal-Wallis
test and Wilcoxon’s signed-rank test were used to examine
intra-group and inter-group differences in VAS scores.
Dunn's post test was used for pairwise comparison fol-
lowing Kruskal-Wallis test. For qualitative variables with
normal distribution, the χ2 test or Fisher’s exact test was
used for count data, as appropriate according to sample
size, and independent-samples t-test or one-way ANOVA
was used for parametric data. Statistical significance wasmized
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Table 1 Baseline characteristics of the 156 endometriosis patients
Group A (n = 52) Group B (n = 52) Group C (n = 52)
Age (years) 28.1 ± 2.2 28.6 ± 5.1 29.44 ± 4.8
Duration of infertility (years) 2.5 ± 1.9 2.7 ± 1.8 2.6 ± 1.6
BMI (kg/m2) 19.8 ± 3.1 20.3 ± 3.1 20.5 ± 2.4
r-AFS stage (n, %)
Stage I 34 (65.38) 30 (57.69) 28 (53.85)
Stage II 18 (34.62) 22 (42.31) 24 (46.15)
VAS pain score 38.5 (32–47) 35 (22–58) 28 (23.5–44.5)
Data are expressed as mean ± standard deviation and median (interquartile range) or as number and percentage (%).
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ducted on intention-to-treat basis according to CON-
SORT criteria. Dropouts were categorized based on their
status at last contact.
Results
Flow of study participants is shown in Figure 1. A total of
163 women with minimal or mild endometriosis were
enrolled, out of which 7 dropped out: 4 delayed their preg-
nancy plan temporarily, and 3 had contraindications for
OCs or had undergone previous medical treatment for
endometriosis. The remaining 156 were randomized into
Group A (n = 52; OC only), Group B (n = 52; OC +Dan’e
mixture) and Group C (n = 52; no medical treatment).
The mean duration of follow-up was 22.17 ± 3.39 months
(range, 14–27 months); three participants were lost to
follow-up (two in Group A and one in Group B) because
their telephone numbers had changed and they could not
be contacted. None of the participants withdrew from the
trial due to side effects. Therefore, 156 cases were finally
included in the intention-to-treat analysis, and the worst-
case scenario was applied in the analysis for the three lost
to follow-up. Baseline characteristics of the intention-to-
treat population are shown in Table 1. The three groups
were comparable with regard to their demographic and
clinical characteristics (P > .05).
A total of 73 pregnancies occurred during nearly two
years of follow-up and the PR was 46.80% (73/156). Among
them, 60 pregnancies occurred within the 12 months afterTable 2 Intention-to-treat analysis of pregnancy and births ac
follow-up
Group A (n = 52)
Pregnancy n (%) 20 (38.46)
Outcome of pregnancy n (%)
Live birth 14 (70.00)
Miscarriage (<28 weeks) 4 (20.00))
Stillbirth (>28 weeks) 1 (5.00)
Ectopic pregnancy 1 (5.00)
Assumption for intention-to-treat analysis: those lost to follow-up did not conceive.
Data were expressed as number and percentage (%).completion of treatment. Among the remaining 13 preg-
nancies that followed, 4 conceived without any additional
treatment, 3 were given medication for induction of ovula-
tion, and 7 underwent ART (IUI, 2; IVF-ET, 5). Up to
now, there have been 51 live births, including cases of 7
preterm labor (LBR, 69.86%; 51/73); among the remaining
pregnancies, miscarriages occurred in 14 cases, stillbirth
in 1 case, and ectopic pregnancies in 3 cases, and the ges-
tational period was longer than 28 weeks in 4 cases.
The pregnancy rate within 12 months of follow-up
was 38.46% (60/156): 20 in Group A (38.46%, 20/52), 16
in Group B (30.77%, 16/52), and 24 in Group C (46.15%,
24/52). There were three cases of ectopic pregnancy
(one in Group A and two in Group C), ten spontaneous
abortions (four in Group A, three in Group B and three
in Group C), and one stillbirth in Group A; therefore,
there were 46 live births (76.67%, 46/60). No significant
difference in PR and LBR was observed between the
three groups (P > .05) (Table 2).
The symptoms of pelvic pain improved and VAS
scores decreased in the three groups at the sixth month
of follow-up compared to the baseline (P < .05). Patients
treated with either OC or OC plus Dan’e mixture had
significantly lower scores than those who received no
medical treatment (P < .05). No significant difference in
pain scores was observed between the two medical treat-
ments (P > .05) (Table 3).
The potentially treatment-related adverse events expe-
rienced irregular vaginal bleeding and breast tenderness.cording to treatment allocation within 12 months of
Group B (n = 52) Group C (n = 52)
16 (30.77) 24 (46.15)
13 (81.25) 19 (79.16)
3 (18.75) 3 (12.50)
0 0
0 2 (8.33)
Table 3 VAS scores over the six-month study period
Group A (n = 52) Group B (n = 52) Group C (n = 52)
Baseline 38.5 (0–63) 35 (0–82) 28 (0–61)
Six months after treatment 15 (0–46) 19 (0–52) 29 (0–56)
Values of pain score are expressed as median (interquartile range).
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these adverse events between the two groups (Table 4).
Discussion
In this prospective, randomized, controlled study, our
main purpose was to evaluate the therapeutic effective-
ness of laparoscopy combined with different medicine
regimens in infertile women with minimal or mild endo-
metriosis. Although a lot of studies have demonstrated
no difference in pregnancy rates with preceding ovula-
tion suppression with oral contraceptives, progestins, or
danazol in infertile women with endometriosis, only a
few trials have investigated whether laparoscopy com-
bined with medical treatment is beneficial for the treat-
ment of women with minimal/mild endometriosis [12].
The spontaneous pregnancy rate within 12 months
was 38.46%, but it is lower than the rate expected in
infertile women after IVF/ICSI treatment (64.6%) [13].
This indicates that endometriosis may not be the sole
factor causing infertility in these women, and therefore
destruction of visible endometriotic implants and adhe-
siolysis may not be sufficient to combat infertility.
As we know, postoperative complementary medication
treatments with minimal/mild endometriosis in women
who wish to conceive is still a controversial issue. In this
study, we chose a continuous 63-day OC administer regi-
men, in order to avoid withdrawal bleeding and effectively
suppress ectopic foci [14,15]. Unfortunately, we did not
find this regimen to have any advantages with regard to
enhancing fertility in these women. Medical suppression
of ovulation delays conception only until the treatment is
completed, and it may in fact be counterproductive in the
case of infertile patients. This drawback becomes even
more pronounced in infertile patients with surgically
treated endometriosis, because traditional post-operative
hormone therapy interferes with ovulation during a cri-
tical period for conception [16].Table 4 Side effects in the medical treatment groups
Group A (n, %) Group B (n, %)
Irregular vaginal bleeding 14 (26.92) 18 (34.62)
Breast tenderness 13 (25.00) 10 (19.23)
Weight gain 9 (17.31) 6 (11.54)
Gastrointestinal discomfort 4 (7.69) 6 (11.54)
Data are expressed as number and percentage (%) and were compared using
the χ2 test or Fisher’s exact.It was reported that the traditional medicine can im-
prove women’s fecundity. As we know, the traditional
medicine usually need longer time to work, the time for
conception after surgery is confined. Therefore, a com-
bination of OC and traditional medicine is designed in
the study to increase the effects of herbs in a short time.
However, we failed to convince improvement of herbs
for women’s fecundity. Both regimen OC alone and
combination of OC and herbs were not more effective at
enhancing fertility compared with surgery alone. One of
drawback in this study is no traditional medicine alone
regimen. We need to conduct a future study in which
the traditional medicine alone be designed to determine
its role for improve female fecundity.
When individual pain scores were assessed at 6 months,
there was a reduction in pain scores in all patients, inde-
pendent of the group to which they were randomized.
This is similar to previously reported rates of response in
women with minimal and mild endometriosis [17]. How-
ever, we found that the pain scores in the two medical
treatment groups were significantly lower than those in
the control group at the 8th and 6th month after surgical
treatment. This is in agreement with the results of present
and past studies, in which the benefits of OCs in man-
aging symptoms associated with endometriosis have been
clearly demonstrated [13,14]. Interestingly, no difference
in pain scores was identified between the two medical
treatment groups.
Miscarriage occurred in approximately 19.30% of the
cases in this study, which suggests an increased inci-
dence in spontaneous abortion and decreased LBR in
women with endometriosis. Similar results were also ob-
served in a multicentric Italian study [18]. The definite
mechanism by which endometriosis may affect spontan-
eous pregnancy loss is as yet undetermined. A putative
luteal-phase defect associated with endometriosis may
be the problem [19]. However, the pathogenesis of the
luteal-phase defect is unclear; it is believed to be caused
by a proliferative phase defect, low expression of inter-
grin and HOX 10, progesterone resistance, or abnor-
mality in the junctional zone, which result in increased
rate of fetal loss in women with endometriosis [20,21].
The pathogenesis of pregnancy loss resulting from endo-
metriosis needs to be studied further.
A major strength of our study is the rigorous rando-
mized, prospective and the sufficient sample size. The
main drawback is the absence of blinding to patients and
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participants to treatment allocation since the treatment
involved the patients themselves taking medication at
home and the control group received no intervention.
Therefore, the present study was not a double-blind study,
and consequently, there might be a bias in favor of the
treatment group.
Conclusions
In conclusion, there is no evidence from this study that
combining surgery with medication with OCs or OCs and
herbs had better benefits in terms of improving fertility
than laparoscopy alone; therefore, we think that in cases
of minimal/mild endometriosis, it is better to conceive
immediately after surgery, as there is a 30% chance of con-
ceiving during the 6–12 month period following laparos-
copy. Those who fail to conceive should be treated with
superovulation/IUI or IVF according to their preferred
choice, the woman’s age and other factors. Moreover,
laparoscopy is effective for relieving pain associated with
minimal/mild endometriosis, but there is no evidence that
medicine combination of OCs and herbal mixtures have
these pain relieving effects better than OCs alone.
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